Integrative Medicine on the treatment of refractory - relapsed acute leukemia clinical research_0.docVIP

Integrative Medicine on the treatment of refractory - relapsed acute leukemia clinical research_0.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Integrative Medicine on the treatment of refractory - relapsed acute leukemia clinical research_0

 PAGE \* MERGEFORMAT 11 Integrative Medicine on the treatment of refractory / relapsed acute leukemia clinical research [Keywords:] leukemia, detoxification Huayu Recipe, Chinese and Western medicine therapy Although refractory acute leukemia and relapsed acute leukemia are two different concepts, but there are similarities between the two, such as poor prognosis and short survival, long-term survival are less so. How to improve the refractory / relapsed acute treatment of leukemia patients, improve outcomes, is currently being explored and research scholars, the problem. the author on the basis of conventional chemotherapy, plus traditional Chinese medicine detoxification Huayu Recipe self oral treatment of refractory / relapsed acute leukemia, and as control group were observed. now following results. 1 Clinical data 1.1 General Information 1.1.1 Incidence Cases, 36 cases of Guangzhou University of Chinese Medicine Department of Hematology, First Affiliated Hospital of hospitalized patients, among them 20 patients with refractory acute leukemia, relapsed acute leukemia in 16 cases, the treatment group, 9 patients are refractory, recurrent in 8 patients in the control group is refractory in 11 cases, 8 cases were recurrent incidence of .2 was no difference between groups was statistically significant. 1.1.2 Distribution of Risk Factors 36 patients, a high white blood cell leukemia in 18 cases, 3 cases of low-proliferative leukemia, secondary leukemia in 1 case, 5 cases of mixed acute leukemia, extramedullary leukemia, 7 patients relapsed after hematopoietic stem cell transplantation in 1 case, age-related leukemia 6 cases of myelodysplastic syndromes into 2 cases. 1.1.3 FAB classification case 36 cases are 14 cases of acute lymphoblastic leukemia (L1 1 例, L2 12 例, L3 1 cases), acute non-lymphocytic leukemia in 22 cases (ML 2 例, M2 10 例, M3 1 例, M4 2 例, M5 1 case, MAL 5 cases). 1.1.4 Grouping By random number table, ID numb

文档评论(0)

hhuiws1482 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:5024214302000003

1亿VIP精品文档

相关文档